about
Dopamine release in the basal gangliaEndocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alphaN-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipaseThe diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarinCannabinoid and opioid interactions: implications for opiate dependence and withdrawalModulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionInhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionInternational Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂Alterations of monetary reward and punishment processing in chronic cannabis users: an FMRI studyAltering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance.The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors.Are CB(1) Receptor Antagonists Nootropic or Cognitive Impairing Agents?Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2.CB1 Cannabinoid Receptor Expression in the Striatum: Association with Corticostriatal Circuits and Developmental Regulation.Exogenous and endogenous cannabinoids suppress inhibitory neurotransmission in the human neocortexSeparate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THC.The intracerebroventricular injection of rimonabant inhibits systemic lipopolysaccharide-induced lung inflammation.The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.Interactions between ethanol and the endocannabinoid system at GABAergic synapses on basolateral amygdala principal neurons.Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocannabinol in humans discriminating [INCREMENT]9-tetrahydrocannabinolPre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans.Cyclooxygenase-2 in synaptic signaling.Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate HomeostasisIn vivo (1)H magnetic resonance spectroscopy in young-adult daily marijuana users.Emerging strategies for exploiting cannabinoid receptor agonists as medicines.Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortexPeripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation.Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol.Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure.Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids.Human Drug Discrimination: Elucidating the Neuropharmacology of Commonly Abused Illicit Drugs.Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks.TRP channels as novel targets for endogenous ligands: focus on endocannabinoids and nociceptive signalling.Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link?Effect of the CB(1) receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slicesNeurochemical Markers in the Mammalian Brain: Structure, Roles in Synaptic Communication, and Pharmacological Relevance.Purine receptor-mediated endocannabinoid production and retrograde synaptic signalling in the cerebellar cortex.The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.
P2860
Q22251247-D292253F-2C2F-48E4-8ACA-7A3406A10F91Q24564778-1EACD5EA-2854-4DE7-A8E1-28376CEC51FBQ24569817-E24F8A95-04EF-471C-9220-FA867080BCECQ24643876-027A8085-7BA6-4C31-8E38-5EA8D05D597AQ27000762-BD8D257D-F309-4FBF-8CEB-C381AB742ECBQ27014154-2D5926E7-5C9B-4102-AF4C-516B48E9EBD3Q28283718-1BC56F58-7405-4D05-9B38-6466240B9D35Q28298445-EC15CA71-1CB5-45B6-96FA-7CAF4ED977B6Q28544894-938E2807-462A-4901-9BE1-943679B2AD09Q30471167-A8909D54-0E63-4582-A906-DF435A62523FQ30733453-53DA6280-79AD-478E-8058-8E1177A5F0B9Q33715462-362A399B-2BDE-43CC-B497-F5D5B4C3DEEAQ33901801-17FD34F5-EAAE-4DF5-BC43-C280A058B330Q35626928-14B21480-A775-40DC-A6C9-6B5DB743529BQ35820005-24EFCCF8-C943-4B8E-BA79-7D64718FF643Q35837682-20A68456-1149-4BA4-924C-B5E45D5D668AQ35840095-0D15C19F-ECA1-414F-BE0E-573BA7A96651Q35992908-FC7756D0-2624-4EF8-8C9E-B32FCA413F07Q36341688-8C6016E8-DFFA-467D-A61B-523FD48B1B84Q36405131-0303AD4B-7766-4923-A20D-0DD8AE223B8FQ36624486-B9874FCD-9402-4E74-BE92-B98CF94361E8Q36677757-3FC27082-CFCC-4F80-9F19-D386224C6B36Q36922736-89D23628-39FA-4EC2-9074-BB0626D695A5Q36953261-17F10DAE-25CA-4137-9979-B8B952A73BC4Q37062547-3BE2A92F-325B-4845-9C5D-B6CA071C4879Q37094864-C6214483-B785-4F0C-9A3A-B43B32A05FA9Q37230665-6A95EEBC-953A-4BE0-8CF6-A38FAEA06C07Q37240007-F7AA5E90-C3A9-45BA-BA26-BD3DD3D384F7Q37258625-56E5297A-7FF6-444F-89C9-2F9840A95E4BQ37266063-B7C8506E-0C5F-42E8-94C2-08E646C4C90DQ37529127-03C51825-2F47-435F-B0EB-B2E68E7703E4Q38056395-693DDC3A-7F91-41A3-A3CE-1FC732009E77Q38856900-159F70C9-067C-42E3-AA4F-DF93A2A208C5Q38957531-DED42DA0-17E8-40AA-8CF4-688E4FAE30A7Q39260828-04E16A68-D600-4E06-B9BB-A292A51713EBQ40548377-5E3C7FCA-4E5B-40E6-97A5-9CCEB057559AQ41938516-92C4277D-3843-4A57-9E0B-44B2A8EB531AQ42380034-E8817040-268B-4274-808D-8F8606925C25Q42618328-3C67EC69-3CB4-4AAF-BD08-555A7094771BQ45047828-DAB35A60-B5D6-4904-A52D-DD2186927186
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Effects of cannabinoids on neurotransmission.
@ast
Effects of cannabinoids on neurotransmission.
@en
type
label
Effects of cannabinoids on neurotransmission.
@ast
Effects of cannabinoids on neurotransmission.
@en
prefLabel
Effects of cannabinoids on neurotransmission.
@ast
Effects of cannabinoids on neurotransmission.
@en
P356
P1476
Effects of cannabinoids on neurotransmission
@en
P2093
P304
P356
10.1007/3-540-26573-2_11
P577
2005-01-01T00:00:00Z